June 1, 2010 — Connective Tissue Gene Tests (CTGT) announced today that it is now offering a proprietary High-Density Targeted Array for more than 50 inherited connective tissue disorders. The new offering will provide physicians with an important new resource for diagnosing these disorders.
CTGT High-Density Targeted (HDT) Array is a custom-designed high-density microarray based on information derived from CTGT’s extensive research and testing experience. This unique solution offers clinicians many important advantages:
- By employing a unique, very high density micro-array technology, CTGT’s tests offer the highest test sensitivity available.
- This methodology is capable of detecting single to multi exon deletions or duplications.
- CTGT’s simple add-on test order process allows clients to easily combine our comprehensive sequencing test methodologies with CTGT Targeted Deletion / Duplication Testing in any order desired.
- Results are reported in concise, easy to interpret reports that facilitate clinical decision making